L. Miglioresi

871 total citations
25 papers, 314 citations indexed

About

L. Miglioresi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, L. Miglioresi has authored 25 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 19 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in L. Miglioresi's work include Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (10 papers). L. Miglioresi is often cited by papers focused on Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (10 papers). L. Miglioresi collaborates with scholars based in Italy, United States and Lebanon. L. Miglioresi's co-authors include C. Lucidi, Daniele Lisi, Giovanni Bruno, Adriano Pellicelli, Pietro Lampertico, Angelo Sangiovanni, Paola Begini, Elsa Iannicelli, Giovanni Vennarecci and Giulio Antonelli and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Journal of Translational Medicine.

In The Last Decade

L. Miglioresi

25 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Miglioresi Italy	9	153	150	107	49	38	25	314
Paola Begini Italy	9	123 0.8×	135 0.9×	72 0.7×	135 2.8×	27 0.7×	22	294
Katharina Pomej Austria	11	191 1.2×	238 1.6×	42 0.4×	33 0.7×	71 1.9×	25	313
Donna R. Cryer United States	8	358 2.3×	254 1.7×	86 0.8×	22 0.4×	59 1.6×	17	483
Moon-Sing Lee Taiwan	11	141 0.9×	106 0.7×	71 0.7×	10 0.2×	77 2.0×	17	406
Sanjay Ramrakhiani United States	8	155 1.0×	110 0.7×	102 1.0×	13 0.3×	86 2.3×	21	309
Kazuhito Sakata Japan	9	97 0.6×	123 0.8×	87 0.8×	87 1.8×	137 3.6×	17	321
Cheng-Shyong Wu Taiwan	8	118 0.8×	111 0.7×	56 0.5×	16 0.3×	123 3.2×	10	319
Manjushree Gautam United States	8	214 1.4×	243 1.6×	116 1.1×	21 0.4×	165 4.3×	16	429
Nancy E. Aguilar-Olivos Mexico	14	301 2.0×	232 1.5×	109 1.0×	43 0.9×	202 5.3×	24	523
Laura Iliescu Romania	10	100 0.7×	90 0.6×	69 0.6×	9 0.2×	85 2.2×	68	295

Countries citing papers authored by L. Miglioresi

Since Specialization

Citations

This map shows the geographic impact of L. Miglioresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Miglioresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Miglioresi more than expected).

Fields of papers citing papers by L. Miglioresi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Miglioresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Miglioresi. The network helps show where L. Miglioresi may publish in the future.

Co-authorship network of co-authors of L. Miglioresi

This figure shows the co-authorship network connecting the top 25 collaborators of L. Miglioresi. A scholar is included among the top collaborators of L. Miglioresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Miglioresi. L. Miglioresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lucidi, C., et al.. (2020). Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program. Clinical Colorectal Cancer. 20(1). e5–e11. 59 indexed citations

Rinaldi, Luca, Alessandro Perrella, Maria Guarino, et al.. (2019). Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study. Journal of Translational Medicine. 17(1). 292–292. 42 indexed citations

Antonelli, Giulio, Elia Gigante, Massimo Iavarone, et al.. (2018). Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. United European Gastroenterology Journal. 6(7). 1039–1048. 51 indexed citations

Piai, G., et al.. (2018). How to Improve Compliance With Dermatologic Screening in Liver Transplant Recipients: Experience in a (Spoke) Peripheral Center for Follow-up. Transplantation Proceedings. 51(1). 184–186. 4 indexed citations

Nosotti, L., Alessio Petrelli, D. Genovese, et al.. (2016). Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment. Journal of Immigrant and Minority Health. 19(4). 876–882. 4 indexed citations

Pellicelli, Adriano, C. D’Ambrosio, Maria Laura Dessanti, et al.. (2015). Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma. Annals of Hepatology. 14(5). 756–761. 4 indexed citations

Ettorre, Giuseppe Maria, Pierluca Piselli, Maria Rendina, et al.. (2013). De Novo Malignancies Following Liver Transplantation: Results From a Multicentric Study in Central and Southern Italy, 1990–2008. Transplantation Proceedings. 45(7). 2729–2732. 37 indexed citations

Ponziani, Francesca Romana, Alessandro Milani, Antonio Gasbarrini, et al.. (2012). Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers. Transplant International. 26(3). 281–289. 6 indexed citations

Giusto, M., Alessio Farcomeni, Francesca Romana Ponziani, et al.. (2012). Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. Transplant International. 25(4). 448–454. 8 indexed citations

10.

Scarlata, Simone, Maria Elisabetta Conte, Matteo Cesari, et al.. (2011). Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease. Liver International. 31(4). 525–533. 7 indexed citations

11.

Ettorre, Giuseppe Maria, Giovanni Vennarecci, Roberto Santoro, L. Miglioresi, & Pasquale Lepiane. (2011). Experiences in Hepatic Surgery and Transplantation after Radioembolization. Journal of Nuclear Medicine & Radiation Therapy. 1(1). 10 indexed citations

12.

Rendina, Maria, N.M. Castellaneta, S. Fagiuoli, et al.. (2011). Obtaining SVR To Antiviral Therapy Highly Protects Patients With HCV Recurrence On The Graft After Liver Transplantation From Liver Related Death: Insights from The AISF-RECOLT-C GROUP.. Gastroenterology. 140(5). S–145. 1 indexed citations

13.

Vero, V., Marco Senzolo, L. Pasulo, et al.. (2011). 578 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?. Journal of Hepatology. 54. S235–S235. 4 indexed citations

14.

Castellaneta, N.M., S. Fagiuoli, Francesca Romana Ponziani, et al.. (2011). 563 ACUTE AND CHRONIC REJECTION DURING INTERFERON THERAPY IN HCV RECURRENT TRANSPLANT PATIENTS: RESULTS FORM THE AISF-RECOLT-C GROUP. Journal of Hepatology. 54. S230–S230. 4 indexed citations

15.

D’Agosto, Giovanna, Elisabetta Trento, L. Nosotti, et al.. (2010). CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.. PubMed. 23(3). 155–64. 13 indexed citations

16.

Ettorre, Giuseppe Maria, Giovanni Vennarecci, Roberto Santoro, et al.. (2007). Modified Liver Hanging Maneuver During Orthotopic Liver Transplantation With Inferior Vena Cava Preservation: Results After 120 Consecutive Applications. Transplantation Proceedings. 39(6). 1881–1882. 4 indexed citations

17.

Miglioresi, L.. (2003). Consensus interferon versus interferon-α 2b plus ribavirin in patients with relapsing HCV infection. Hepatology Research. 27(4). 253–259. 23 indexed citations

18.

Russo, Francesca, et al.. (2001). Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor. European Journal of Gastroenterology & Hepatology. 13(11). 1347–1354. 14 indexed citations

19.

Miglioresi, L., et al.. (2001). What Kind of Hepatitis?. Journal of International Medical Research. 29(5). 441–444. 2 indexed citations

20.

Mercurio, Giovanna, Andrea Di Lorenzo, Clarissa Berardo, et al.. (1999). Elevated Alanine Aminotransferase in Blood Donors: Role of Different Factors and Multiple Viral Infections. Journal of International Medical Research. 27(3). 134–142. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact